The discovery of new PF4-related immune disorders underlying VTE during the pandemic has opened new avenues in thrombosis research, requiring further evaluations of new biological detection methods and clinical diagnostics approach to enhance patient care. The gene discussed is PF4; the disease is immune system disorder.